Results 231 to 240 of about 131,451 (349)

Disparities in Proton Radiation Utilization for HPV‐Associated Oropharyngeal Cancer Following TORS

open access: yesHead &Neck, Volume 48, Issue 5, Page 1218-1224, May 2026.
ABSTRACT Introduction Racial, socioeconomic, and geographic disparities in receipt of proton radiation have been reported. Whether disparities exist for oropharyngeal squamous cell carcinoma (OPSCC) is not well studied. Methods Patients with HPV‐associated OPSCC treated with transoral robotic surgery (TORS) and adjuvant radiation from 2016 to 2023 were
Jane Y. Tong   +4 more
wiley   +1 more source

EP-1192 Hair loss during intensity modulated radiotherapy for nasopharyngeal carcinoma

open access: bronze, 2019
N. Fourati   +6 more
openalex   +1 more source

Predicting optimal impact interventions in the post‐HPV vaccination world

open access: yesInternational Journal of Cancer, Volume 158, Issue 9, Page 2262-2271, 1 May 2026.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen   +7 more
wiley   +1 more source

Small Business Grants Awarded by the National Institutes of Health for Rhinologic Diseases, 1985–2024

open access: yes
International Forum of Allergy &Rhinology, Volume 16, Issue 5, Page 512-515, May 2026.
Jack Birkenbeuel   +7 more
wiley   +1 more source

Transcriptional Expression of RPMS1 in Nasopharyngeal Carcinoma and Its Oncogenic Potential [PDF]

open access: bronze, 2004
Ang Li   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy